EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic: A comprehensive review

Edoardo Caronna iD, Thomas C van den Hoek, Hayrunnisa Bolay iD, David Garcia-Azorin iD, Ana Beatriz Gago-Veiga, Massimiliano Valeriani iD, Tsubasa Takizawa, Karl Messlinger iD, Robert E Shapiro, Peter J Goadsby iD, Messoud Ashina, Cristina Tassorelli iD und 3 weitere

Cephalalgia · 2023

DOI: 10.1177/03331024221131337 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cephalalgia, 2023. Verfasst von Edoardo Caronna und 14 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Department, Hospital Universitari Vall d'Hebron, Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain. Hauptthemen laut MEDLINE: COVID-19, Migraine Disorders. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The objective is to summarize the knowledge on the epidemiology, pathophysiology and management of secondary headache attributed to SARS-CoV-2 infection and vaccination; as well as to delineate their impact on primary headache disorders.

Methods

This is a narrative review of the literature regarding primary and secondary headache disorders in the setting of COVID-19 pandemic. We conducted a literature search in 2022 on PubMed, with the keywords “COVID 19” or “vaccine” and “headache” to assess the appropriateness of all published articles for their inclusion in the review.

Results

Headache is a common and sometimes difficult-to-treat symptom of both the acute and post-acute phase of SARS-CoV-2 infection. Different pathophysiological mechanisms may be involved, with the trigeminovascular system as a plausible target. Specific evidence-based effective therapeutic options are lacking at present. Headache attributed to SARS-CoV-2 vaccinations is also common, its pathophysiology being unclear. People with primary headache disorders experience headache in the acute phase of COVID-19 and after vaccination more commonly than the general population. Pandemic measures, forcing lifestyle changes, seemed to have had a positive impact on migraine, and changes in headache care (telemedicine) have been effectively introduced.

Conclusions

The ongoing COVID-19 pandemic is a global challenge, having an impact on the development of secondary headaches, both in people with or without primary headaches. This has created opportunities to better understand and treat headache and to potentiate strategies to manage patients and ensure care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Migraine DisordersHumansPandemicsSARS-CoV-2Headache

Stichwörter der Autor:innen

COVID-19HeadacheSARS-CoV-2migrainetelemedicinevaccine

Autor:innen und Institutionen

  • Neurology Department, Hospital Universitari Vall d'Hebron, Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Headache and Neurological Pain Research Group, Vall d'Hebron Research Institute, Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands.
  • Department of Neurology and Algology, NÖROM, Gazi University Hospital, Ankara, Turkey.
  • Headache Unit, Department of Neurology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
  • Department of Medicine, Universidad de Valladolid, Valladolid, Spain.

ORCID-Profile: Edoardo Caronna, Hayrunnisa Bolay, David Garcia-Azorin, Massimiliano Valeriani, Karl Messlinger, Peter J Goadsby, Cristina Tassorelli, Hans-Christoph Diener, Patricia Pozo-Rosich

Zitieren

APA

Caronna, E., van den Hoek, T. C., Bolay, H., Garcia-Azorin, D., Gago-Veiga, A. B., Valeriani, M., Takizawa, T., Messlinger, K., Shapiro, R. E., Goadsby, P. J., Ashina, M., Tassorelli, C., Diener, H. C., Terwindt, G. M., & Pozo-Rosich, P. (2023). Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic: A comprehensive review. Cephalalgia. https://doi.org/10.1177/03331024221131337

Vancouver

Caronna E, van den Hoek TC, Bolay H, Garcia-Azorin D, Gago-Veiga AB, Valeriani M, et al. Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic: A comprehensive review. Cephalalgia. 2023. doi:10.1177/03331024221131337

BibTeX
@article{Caronna2023,
  author = {Caronna, Edoardo and van den Hoek, Thomas C and Bolay, Hayrunnisa and Garcia-Azorin, David and Gago-Veiga, Ana Beatriz and Valeriani, Massimiliano and Takizawa, Tsubasa and Messlinger, Karl and Shapiro, Robert E and Goadsby, Peter J and Ashina, Messoud and Tassorelli, Cristina and Diener, Hans-Christoph and Terwindt, Gisela M and Pozo-Rosich, Patricia},
  title = {Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic: A comprehensive review},
  journal = {Cephalalgia},
  year = {2023},
  doi = {10.1177/03331024221131337}
}
Kostenlos starten →